Contact this trialFirst, we need to learn more about you.
Bradykinin B2 Receptor Inhibitor
Icatibant for Intradialytic Hypotension
Recruiting1 awardPhase 3
Nashville, Tennessee
This trial seeks an alternative to current treatments for patients on hemodialysis suffering from recurrent IDH episodes. There is currently no medication available, so medical interventions are the main methods used to maintain blood pressure. New treatments may reduce mortality rate and give clinicians additional options.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.